160 related articles for article (PubMed ID: 11720743)
21. Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer.
Baillie R; Carlile J; Pendleton N; Schor AM
J Clin Pathol; 2001 Feb; 54(2):116-20. PubMed ID: 11215279
[TBL] [Abstract][Full Text] [Related]
22. Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma.
Fontanini G; Boldrini L; Vignati S; Chinè S; Basolo F; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Eur J Cancer; 1998 Apr; 34(5):718-23. PubMed ID: 9713280
[TBL] [Abstract][Full Text] [Related]
23. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.
Masuya D; Huang C; Liu D; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Haba R; Yokomise H
Cancer; 2001 Nov; 92(10):2628-38. PubMed ID: 11745198
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.
Ambs S; Bennett WP; Merriam WG; Ogunfusika MO; Oser SM; Khan MA; Jones RT; Harris CC
Br J Cancer; 1998 Jul; 78(2):233-9. PubMed ID: 9683299
[TBL] [Abstract][Full Text] [Related]
25. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
Zietz C; Rössle M; Haas C; Sendelhofert A; Hirschmann A; Stürzl M; Löhrs U
Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.
Mitsudomi T; Oyama T; Kusano T; Osaki T; Nakanishi R; Shirakusa T
J Natl Cancer Inst; 1993 Dec; 85(24):2018-23. PubMed ID: 8246288
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
[TBL] [Abstract][Full Text] [Related]
28. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
29. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC
Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890
[TBL] [Abstract][Full Text] [Related]
30. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status.
Maeda T; Matsumura S; Hiranuma H; Jikko A; Furukawa S; Ishida T; Fuchihata H
J Clin Pathol; 1998 Oct; 51(10):771-5. PubMed ID: 10023341
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression.
Lee JS; Kim HS; Jung JJ; Park CS; Lee MC
J Surg Oncol; 2001 May; 77(1):55-60. PubMed ID: 11344484
[TBL] [Abstract][Full Text] [Related]
32. [Vascular endothelial growth factor in non-small cell lung carcinoma expression and its significance].
Yang G; Zhang L; Xie Y
Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):104-5. PubMed ID: 11601013
[TBL] [Abstract][Full Text] [Related]
33. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
Pal S; Datta K; Mukhopadhyay D
Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
35. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis.
Uchida S; Shimada Y; Watanabe G; Tanaka H; Shibagaki I; Miyahara T; Ishigami S; Imamura M
Br J Cancer; 1998 May; 77(10):1704-9. PubMed ID: 9635853
[TBL] [Abstract][Full Text] [Related]
36. p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.
Ahrendt SA; Hu Y; Buta M; McDermott MP; Benoit N; Yang SC; Wu L; Sidransky D
J Natl Cancer Inst; 2003 Jul; 95(13):961-70. PubMed ID: 12837832
[TBL] [Abstract][Full Text] [Related]
37. Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas.
Ahn MJ; Jang SJ; Park YW; Choi JH; Oh HS; Lee CB; Paik HK; Park CK
J Korean Med Sci; 2002 Apr; 17(2):201-7. PubMed ID: 11961303
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung.
Minami K; Saito Y; Imamura H; Okamura A
Lung Cancer; 2002 Oct; 38(1):51-7. PubMed ID: 12367793
[TBL] [Abstract][Full Text] [Related]
39. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
40. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
